Hallandale Pharmacy peptide formulary: catalog and regulatory status
Hallandale Pharmacy lists Peptide Therapy as a dedicated product category on hallandalerx.com. Third-party sources confirm their active peptide compounds include BPC-157, sermorelin, ipamorelin, and PT-141 (bremelanotide). Glutathione 200 mg/mL in a 30 mL injectable vial is also listed on their public product page, relevant to longevity and peptide programs. As with all of Hallandale's formulary, per-unit rates are not published — clinics contact Hallandale directly for pricing.
A critical caveat for any 503A peptide program: in 2023, the FDA finalized removal of several peptides from the list of bulk drug substances eligible for compounding under 503A rules. This affects what any 503A compounder — including Hallandale — can legally prepare. Before building a menu around specific peptides, confirm with your prescriber that each molecule remains eligible for 503A compounding, and confirm with Hallandale that they can legally prepare it. This is a platform-agnostic regulatory issue.